Colorectal cancer, screening and survival: The influence of socio-economic deprivation

Public Health

Volumn 117, Issue 6, 2003, Pages 389-395

  Whynes, David K ^a   Frew, E J ^b   Manghan, C M ^a   Scholefield, J H ^a   Hardcastle, J D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Colorectal cancer; Deprivation; Life expectancy; Screening; Survival

Indexed keywords

CANCER;

ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SOCIAL STATUS; SOCIOECONOMICS; SURVIVAL RATE; UNITED KINGDOM;

EID: 0142212262     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(03)00146-X     Document Type: Article

References (38)

1. International Agency for Research on Cancer. Cancer Incidence, Mortality and Prevalence in the European Union, EUCAN 1997 Estimates; 2002. www-dep.iarc.fr/ eucan/eucan.htm.
2. Mulcahy HE, Farthing MJG, O'Donoghue DP. Fortnightly review: screening for asymptomatic cancer. BMJ 1997;314:285-91.
3. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998;317:559-65.
4. Hardcastle JD, Farrands PA, Balfour TW, Chamberlain JO, Amar SS, Sheldon MJ. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 1983; ii:1-4.
5. Hardcastle JD, Thomas WM, Chamberlain J, Sheffield J, Balfour TW, Armitage NC, Pye G, James PD, Amar SS, Moss S. Randomised controlled trial of faecal occult blood screening for colorectal cancer: results for the first 107,344 patients. Lancet 1989;i:1160-4.
6. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
7. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002; 50:840-4.
8. Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Faecal occult blood screening for colorectal cancer: is it cost-effective ? Health Econ 1998;7:21-9.
9. Whynes DK. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial. Crit Rev Oncol Hematol 1999;32:155-65.
10. Hardcastle JD, Balfour TW, Amar SS. Screening for symptomless colorectal cancer by testing for occult blood in general practice. Lancet 1980;i:791-3.
11. Carstairs V, Morris R. Deprivation and health in Scotland. Aberdeen: Aberdeen University Press; 1991.
12. Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the North. Andover: Croom Helm; 1989.
13. Department of the Environment Transport and the Regions, Measuring multiple deprivation at the small area level: the indices of deprivation 2000. London: DETR; 2000.
14. Index Team-University of Oxford. http: //www.statistics.gov.uk/ neighbourhood, dataset J1ward. London: DETR; 2001.
15. Whynes DK, Thornton P. Measuring concentration in primary care. Health Care Manag Sci 2000;3:43-9.
16. Lovett A, Haynes R, Sunnenberg G, Gale S. Car travel time and accessibility by bus to general practitioner services: a study using patient registers and GIS. Soc Sci Med 2002;55: 97-111.
17. Reijneveld SA, Verheij RA, de Bakker DH. The impact of area deprivation on differences in health: does the choice of the geographical classification matter? J Epidemiol Commun Health 2000;54:306-13.
18. Huff NC, Gray D. Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England. Health Place 2001;7:57-61.
19. Field KS, Briggs DJ. Socio-economic and locational determinants of accessibility and utilization of primary health care. Health Soc Care Commun 2001;9:294-308.
20. Gatrell A, Garnett S, Rigby J, Maddocks A, Kirwan M. Uptake of screening for breast cancer in south Lancashire. Public Health 1998; 112:297-301.
21. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D, Reeves G, English R, Taylor S, Elliman J, Harris CL. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 2002;4:R1.
22. Bentham G, Hinton J, Haynes R, Lovett A, Bestwick C. Factors affecting non-response to cervical cytology screening in Norfolk, England. Soc Sci Med 1995;40:131-5.
23. lbbotson T, Wyke S, McEwan J, Macintyre S, Kelly M. Uptake of cervical screening in general practice: effect of practice organisation, structure and deprivation. J Med Screen 1996; 3:35-9.
24. Eiser JR, Pendry I, Greaves CJ, Melia J, Harland C, Moss S. Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening. J Med Screen 2000;7:199-202.
25. Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med 1995;41:365-74.
26. UK Flexible Sigmoidoscopy Screening Trial Investigators, Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300.
27. Sutton S, Wardle J, Taylor T, McCaffery K, Williamson S, Edwards R, Cuzick J, Hart A, Northover J, Atkin W. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 2000; 7:99-104.
28. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales. Office of National Statistics Studies on Medical and Population Subjects 66, London: The Stationery Office; 2001.
29. Wakefield SE, Wheeler DW, Mortenson NJ, Kettlewell MG. The incidence and Dukes' staging of colorectal cancer over 3 decades. Eur J Surg Oncol 1998; 24:525-7.
30. Pollock AM, Vickers N. Breast, lung and colorectal cancer inci-dence and survival in South Thames region, 1987-1992: the effect of social deprivation. J Public Health Med 1998; 19:236-8.
31. Kee F, Wilson R, Currie S, Sloan J, Houston R, Rowlands B, Moorehead J. Socioeconomic circumstances and the risk of bowel cancer in Northern Ireland. J Epidemiol Commun Health 1996;50:640-6.
32. Haining R, Wise S, Blake M. Constructing regions for small area analysis: material deprivation and colorectal cancer. J Public Health Med 1994; 16:429-38.
33. Coleman MP, Babb P, Sloggett A, Quinn M, De Stavola B. Socioeconomic inequalities in cancer survival in England and Wales. Cancer 2001;91:208-16.
34. Hole DJ, McArdle CS. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg 2002;89:586-90.
35. Kim Y-E, Gatrell AC, Francis BJ. The geography of survival after surgery for colorectal cancer in southern England. Soc Sci Med 2000;50:1099-107.
36. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J. Inequalities in survival for colorectal cancer: a comparison of the impact of deprivation, treatment and host factors on observed and cause specific survival. J Epidemiol Commun Health 2002;57:301-9.
37. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 2002; 86:331-5.
38. Wichmann MW, Muller C, Hornung HM, Lau-Werner U, Schildberg FW, the Colorectal Cancer Study Group. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 2001; 88:1092-8.